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Correlation of CIMT and disease Activity in Takayasu 
Arteritis (c-CAT study) 
 
ABSTRACT 
Background:  Clinical analysis of Takayasu Arteritis (TA) disease activity, response to 
treatment and detection of relapse remains suboptimal. The currently used NIH criteria 
demand an invasive procedure and have other limitations. B-mode carotid ultrasound is a 
safe, reliable and non-invasive method of measuring CIMT which may have a role as a 
marker of disease activity.  
 
Objective: To assess correlation of Carotid Intima-Medial Thickness (CIMT) with 
disease activity in patients with Takayasu’s arteritis (TA). 
 
Methods:  An observational study on 41 consecutive patients with TA seen in the 
Cardiology department from August 2008 to January 2010. Disease activity was assessed 
in these patients using (i) acute phase reactants- ESR, CRP (ii) NIH (National Institute of 
Health) criteria, & (iii) ITAS score (Indian Takayasu arteritis Activity Score. 
Angiographic extent of the disease was also assessed at enrollment. CIMT images were 
acquired with a high-end ultrasound system, at end diastole. CIMT were then measured 
in the proximal, mid & distal common carotid artery on both the left & right side.  
CIMT was also measured in 30 healthy controls, of a similar age group as the study 
population. 
 
Results: A total of 41 patients were studied. The male, female ratio was approximately 
1:4. CIMT was increased in patients with Takayasu arteritis as compared to the controls. 
The mean CIMT among the study population was 0.85 ± 0.30, which was significantly 
higher than that of the controls which was 0.50 ± 0.06 (p = 0.00). Patients with active 
disease (CIMT = 1.05 ± 0.33) had higher values than those with inactive disease (CIMT = 
0.73 ± 0.20). CIMT ≥ 0.80mm was found to have a statistically significant association 
with ESR ≥ 40mm in 1 hour, NIH score ≥ 2, and ITAS score ≥ 3. CIMT ≥ 0.80mm has a 
sensitivity of 86% & a specificity of 61% in the detection of active TA. 
 
Conclusion:  
Abnormal CIMT (CIMT ≥ 0.80mm) is an easily available & economical tool that can be 
used to reliably assess disease activity in patients with TA. 
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INTRODUCTION 
 
Takayasu Arteritis (TA) is a chronic vasculitis of uncertain etiology involving the large 
elastic arteries. TA is widely recognized as a multifactorial disease, although a genetic 
factor has been suggested as its cause because of predominance in young females from 
the Orient. The disease onset is insidious, and prominent symptoms are nonspecific or 
absent in majority of the patients in the early stage. Moreover the clinical features differ 
with geographical location. Hence a high index of suspicion is needed to make the correct 
diagnosis. The gold standard to confirm the diagnosis is aortography. The course and 
prognosis of patients with TA show wide variation. 
 
Detailed assessment of disease extent and activity are essential to follow both the long 
term outcome and the response to therapy in TA. Serological tests have proved unreliable 
in distinguishing active from quiescent disease. The main problem here is assessing 
activity in a disease where so much of the pathology is located in deep-seated vessels, 
progressing at a slow pace and not necessarily associated with any acute phase response. 
The need is to develop techniques that will allow activity to be assessed independently of 
acute clinical events, such as vessel occlusion. Non-invasive imaging currently is a 
promising tool for early diagnosis, detection of disease activity and monitoring response 
to treatment.   Assessment of inflammation in the vessel wall by MRI or PET may allow 
reliable assessment of disease activity.  However these techniques are expensive & are 
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not widely available. The establishment of a gold standard for activity should at least 
provide the necessary anchor for clinical studies.  
 
An increase in Carotid Intimal Medial Thickness (CIMT) in inflammatory conditions 
such as rheumatoid arthritis, psoriatic arthritis, Behcet’s disease and Takayasu’s arteritis 
has been demonstrated. B-mode carotid ultrasound is a safe, reliable and non-invasive 
method of measuring CIMT.  Therefore we undertook this study to evaluate the role of 
CIMT as a marker of disease activity, in patients with TA. 
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AIMS & OBJECTIVES 
 
Aims: 
 
1. To assess correlation of Carotid Intimal Medial Thickness (CIMT) with disease activity 
in patients with Takayasu’s arteritis (TA).  
 
 
Objectives: 
 
1. To detect the association of an abnormal CIMT with the currently used parameters of 
disease activity, in patients with TA. 
 
2. To assess the sensitivity & specificity of an abnormal CIMT (CIMT ≥ 0.80mm) to 
detect active TA. 
 
3. To detect the cutoff point of CIMT that yields the best sensitivity & specificity to detect 
active disease, using the currently available parameters of disease activity. 
 
 
 
 
 12 
 
 
REVIEW OF LITERATURE 
 
Takayasu arteritis (TA) is classically described as a chronic, progressive, inflammatory, 
disease involving the large elastic arteries mainly the aorta and its major branches as well 
as the pulmonary artery and its branches. The inflammation leads to stenosis and 
occlusion of the involved artery or aneurysm formation or both. The arterial lesions can 
lead to secondary hypertension, retinopathy, cardiac involvement, cerebrovascular events, 
and premature death. The course and prognosis of patients with aortoarteritis show wide 
variation.  In addition to substantial morbidity, mortality has been reported to be as high 
as 20% at 5 yrs1. A small percentage of patients experience a self-limiting monophasic 
inflammatory episode, which does not require chronic immunosuppressive therapy and 
does not progress to the occlusive stage. 
 
History 
 
The first description of this morbid condition was in 1830 by Yamamoto in Japan17. 
However, the first scientific presentation of Takayasu Arteritis was made in 1905 at the 
12th annual meeting of the Japan Ophthalmology Society in Fukuoka by Mikito 
Takayasu describing a case of a 21-year old girl who showed a peculiar optic fundal 
finding - a peculiar wreathlike arteriovenous anastomosis around the papillae of the retina 
(Takayasu disease)2.  In 1940 Ohta confirmed that this characteristic optic fundal feature 
resulted in ischemia due to the obstruction of cervical vessels18.  This disease has come to 
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be called Takayasu Arteritis in honor of the first reporter. At that meeting both Dr. 
Ohnishi and Dr. Kagoshima both pointed out that in their patients no radial pulse could 
be palpated.  In 1951, Shimizu and Sano summarized the clinical features of this 
“pulseless disease”3  
 
Epidemiology 
 
TA is rare, but most commonly seen in Japan, South East Asia, India, and Mexico. It is 
the third commonest vasculitis in childhood worldwide. A study of North American 
patients by Hall et al found the incidence to be 2.6/million/year4. TA is the most common 
cause of renovascular hypertension in India, China, Korea, Japan and other countries of 
South East Asia.  
The disease commonly presents in the 2nd or 3rd decade of life, often with a delay in 
diagnosis from the onset of first symptoms of months to years. In one of the cohorts5 (n = 
107) 80% of patients were between 11 and 30 years, 77% had disease onset between the 
ages of 10 and 20 years. The time from onset of symptoms to diagnosis was 2 to 11 years 
in 78%. A study of 88 patients from India1 found the age at symptom onset to be 24.0 ± 
8.8 years and the  age at diagnosis to be 28.3 ± 9.9 years. The National Institute of Health 
study by Kerr et al suggested that the delay in diagnosis was longer in juveniles, being up 
to four times that of adult patients35. However, data from India6 looking at patients aged 
less than 18 years demonstrated a delay of only 2.5 to 5.5 months. This presumably 
reflects the higher incidence & hence increased clinical awareness.  
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The disease has a predilection for females with wide geographical variations; in Japan it 
is 8: 1, in Mexico 5: 1, in India 4: 17and in Israel 1.2: 1.  In a series by Panja et al8 from 
India, F:M ratio was 6.4 : 1. 
 
Pathology 
 
Aortoarteritis is a panarteritis involving all the three layers of the arterial wall causing 
extensive intimal proliferation, inflammation of media and adventitia followed by marked 
fibrous scarring9. 
In the acute stage of large vessel vasculitis, adventitial vessels of the arterial walls (vasa-
vasorum) become inflamed. The media is infiltrated by lymphocytes & occasional gaint 
cells with neovascularisation. Neovessels originate at the junction of the media and 
adventitia, and subsequently fan out to incorporate the entire media10. The intima 
becomes thickened, with depositions of mucopolysaccharides, smooth muscle cells, and 
fibroblasts. 
 The arteritis then progresses to a chronic sclerotic stage, with intimal and adventitial 
fibrosis and scarring of the media. Histologically there is round cell infiltration, cuffing 
of vasa vasorum and destruction of tunica media leading ultimately to gross fibrosis. In 
older cases, hyalinization of deeper layers of intima and dystrophic calcification can be 
seen. The appearance of aortic intima is closely related to the activity and duration of the 
disease. Circumferential intimal thickening, plaques and patches of raised intima are 
frequently seen on the inner surface of the aorta. In advanced stage, the aortic intima may 
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have ‘tree-bark’ appearance similar to that of luetic aortitis11.  Skipped areas of aortic 
involvement are quite characteristic of aortoarteritis. 
Aneurysm formation also occurs, as an abnormal response to mural stress because of 
inflammation, and may be exacerbated by increased volume, as with aortic regurgitation. 
Infection, particularly, tuberculosis has been implicated in the pathogenesis of this 
disease. However a causal immunopathogenic relationship is still unclear. 
 
Clinical Features 
 
TA classically exhibits a triphasic pattern of expression consisting of a systemic non-
vascular phase, a vascular inflammatory phase, and a quiescent, “burnt out” phase4. 
However, this classic presentation holds true only in a minority of patients because both 
inflammatory and fibrotic changes may coexist at one time owing to the chronic and 
recurrent nature of TA12.  During the early systemic non-vascular phase, nonspecific 
systemic symptoms and signs predominate, albeit often unrecognised. The late phase is 
characterised by ischaemia, and symptoms secondary to arterial occlusion. Recurrent 
disease often occurs in new arterial territories, with the coexistence of active and 
quiescent disease.  
Symptoms and signs include13  
1) Fever, breathlessness, hemoptysis, headache, dizziness, vertigo, angina, chest 
wall pain and claudication pain.  
2) Diminished or absent pulses in 84–96% of patients, resulting in discrepancies 
of blood pressure between limbs. 
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3) Hypertension in 1/3rd to 3/4ths of patients. Marked narrowing of the aorta is 
associated with renovascular disease in up to 2/3rds with reduced aortic 
elasticity and aortic regurgitation in about 1/4th. 
4) Vascular bruits in 4/5ths of patients, often multiple, and particularly affecting 
the carotids, subclavian, and abdominal vessels. 
5) Aortic regurgitation resulting from dilatation of the ascending aorta, 
separation of the valve leaflets, and valve thickening in 20–24% 
6) Takayasu retinopathy in up to 37% of patients whereas hypertensive 
retinopathy is seen in 1/3rd.  
7) Congestive cardiac failure associated with hypertension, aortic regurgitation, 
and dilated cardiomyopathy 
8) Coronary arterial disease is seen in 1/10th.  Three types of disease is identified 
(a) stenosis or occlusion of ostia and proximal segments of coronary arteries 
(b) diffuse or focal coronary arteritis (diffuse involvement or “skip lesions”) 
(c) coronary arterial aneurysms  
9) Pulmonary artery involvement in 14–100% of patients, depending on the 
method used to assess pulmonary vasculature. Oligaemic lung fields on plain 
chest x ray correlate with pulmonary vasculopathy in approximately a third of 
cases. Pulmonary artery disease shows little correlation with the systemic 
pattern of arterial involvement. 
10) Neurological features secondary to hypertension and/or ischaemia, including 
postural dizziness, seizures, and amaurosis 
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11) Other symptoms include dyspnoea, headaches, carotodynia, myocardial 
ischaemia, chest wall pain, and erythema nodosum. 
 
Establishing the diagnosis  
 
 The American College of Rheumatology(1990) has established diagnostic criteria for 
Takayasu arteritis as follows14:-  
1. Age of 40 years or younger at disease onset 
2. Claudication of the extremities (Development & worsening of  fatigue & 
discomfort in muscles of 1 or more extremity while in use, especially the upper 
extremity) 
3. Decreased pulsation of one or both brachial arteries 
4. Difference of more than 10 mmHg in systolic blood pressure between arms 
5. Bruit audible on auscultation over one or both subclavian arteries or the 
abdominal aorta 
6. Arteriographic narrowing or occlusion of the entire aorta, its primary branches, or 
large arteries in the upper or lower extremities that is not due to arteriosclerosis, 
fibromuscular dysplasia, or other causes. 
Presence of at least 3 of these 6 criteria suggests the diagnosis of aortoarteritis, which 
have a sensitivity of 90.5% and a specificity of 97.8%. 
The gold standard to confirm the diagnosis of Takayasu arteritis is however, aortography. 
 
Modified version of Ishikawa diagnostic criteria for Takayasu arteritis15: 
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3 major criteria:  
1. Left mid-subclavian artery lesion 
2. Right mid-subclavian artery lesion 
3. Characteristic signs & symptoms of at least 1 month duration 
10 minor criteria:  
1. ESR > 20mm/hr 
2. Carotid artery tenderness 
3. Hypertension  
4. Aortic regurgitation or annulo-aortic ectasia 
5. Pulmonary artery lesion 
6. Left mid-Common Carotid artery lesion  
7. Distal brachio-cephalic trunk lesion 
8. Descending Thoracic aorta lesion 
9. Abdominal aorta lesion 
10. Coronary artery lesion 
Presence of 2 major & 2 or 4 minor criteria suggest a high probability of TA, which has a 
diagnostic sensitivity and specificity of 92.5 and 95%. 
 
Classification of Takayasu’s arteritis 
 
In 1994, the Xlth International Conference on Takayasu Arteritis established a new 
classification of angiographic findings as below16 :-      
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Type        Vessel involvement 
Type I  Branches from the aortic arch 
Type IIa  Ascending aorta, aortic arch and its branches 
Type IIb  Ascending aorta, aortic arch and its branches, thoracic descending aorta 
Type III  Thoracic descending aorta, abdominal aorta, and/or renal arteries 
Type IV  Abdominal aorta and/or renal arteries 
Type V  Extensive involvement of whole length of aorta and/or its branches 
Involvement of coronary or pulmonary arteries is designated as C (+) or P (+). 
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Varied Clinical Spectrum  
 
Takayasu Arteritis is more prevalent in Asian and South American nations. However the 
variable disease presentation between different populations is well illustrated by 
Moriwaki et al in their study of Indian and Japanese patients16. The Japanese patients (n = 
80) were predominantly female (96%), presenting with dizziness, vertigo, pulselessness, 
more prolonged and severe inflammation, and more aortic regurgitation, reflecting 
involvement of the aortic arch and its main branches. This contrasted with the Indian 
patients (n = 102), 37% of whom were male. They tended to present with headache, 
hypertension, and left ventricular hypertrophy suggesting a high frequency of lesions in 
the abdominal aorta, including the renal arteries, leading to renovascular hypertension.  
However, most patients in both countries had diffuse disease.    
 
Sen et al. and Chhertri et al. have reported a female to male ratio of 1.58:1 in Indian 
patients17.  Indian male patients with TA have a higher frequency of hypertension and 
abdominal aorta involvement while female patients have a tendency towards involvement 
of aortic arch and its branches. The average age of the Indian patient presentation is in the 
third decade. 
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Frequencies of complicated diseases in Takayasu Arteritis between Japan & India18. 
 
Comparison of angiographic types in Takayasu Arteritis between Japan, India & 
Thailand18 
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Clinical Classification of Takayasu disease (as described by Ishikawa) & Prognosis 
 
Severity of aortoarteritis: The patients are classified into four groups according to the 
presence and severity of four major complications at the time of initial assessment, as 
described by Ishikawa20.  
 
 
Group Clinical features 5yr survival rate 
from diagnosis 
1 Uncomplicated disease with or without involvement of the 
pulmonary arteries 
100% 
2 Aortoarteritis associated with one of the following 
complications: (a) retinopathy, (b) secondary hypertension, 
(c) aortic regurgitation (d) aortic or arterial aneurysm 
 
2a Severity of the complication: mild to moderate 100% 
2b Severity of the complication: severe 70-80% 
3 Aortoarteritis associated with two or more complications 70-80% 
 
Complications of aortoarteritis: 
A) Retinopathy:  Estimation of the severity of Takayasu's retinopathy is made according 
to Uyama and Asayama's classification21  
stage 1: dilatation of small vessels;  
stage 2: microaneurysm formation; 
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stage 3: arterio-venous anastomoses; 
stage 4: ocular complications.  
The mild and moderate forms are identical with stages 1 and 2, respectively. The severe 
form is equivalent to stages 3 and 4. 
B) Hypertension: values were graded according to20:  
mild form : 140 to 159 mm Hg brachial systolic and/or 90 to 94 mm Hg diastolic, 
               or 160 to 179 mm Hg popliteal systolic and/or 90 to 94 mmHg diastolic;  
severe form : ≥ 200 mm Hg brachial systolic and/or  ≥ 110 mm Hg diastolic, or  
                      ≥ 230 mm Hg popliteal systolic and/or ≥ 110 mm Hg diastolic;  
moderate form - between the mild and severe forms. 
C) Aortic or arterial aneurysm: Severity of aneurysm of the aorta and its main branches 
was assessed by angiography. Severe aneurysm was defined as a diameter more than 
twice that of normal vessels. The reported incidence of aneurysms in Takayasu's disease 
varies from 2 to 14%20. 
D) Aortic regurgitation was estimated angiographically or clinically. Aortic regurgitation 
of grades 3 or 4 was defined as severe aortic regurgitation. The reported incidence of 
aortic incompetence in Takayasu's disease varies from 7% to 15%20. 
Other cardiac complications.  
i) Mitral regurgitation was diagnosed and graded by clinical and/or angiographic 
examination.  
ii) Cardiomyopathy was diagnosed when the patient had congestive heart failure 
or    ventricular dysfunction out of proportion to the degree of hypertension, 
valvular incompetence, or coronary artery involvement. 
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Natural History 
 
TA  usually extends for many years, with varying degrees of activity in the different 
lesions. TA classically exhibits a triphasic pattern of expression consisting of a systemic 
non-vascular phase, a vascular inflammatory phase, and a quiescent, “burnt out” phase4. 
However, this classic presentation holds true only in a minority of patients because both 
inflammatory and fibrotic changes may coexist at one time owing to the chronic and 
recurrent nature of TA. The natural history of TA often has two distinct phases - an active 
or pre-pulseless phase and a chronic or pulseless phase. Active phase may remit 
spontaneously in 3 months or may progress insidiously into the chronic phase. There can 
be exacerbations of activity during the chronic illness. Not all patients have a manifest 
acute phase and may present in chronic phase only. In the chronic phase, the 
inflammation leads to either stenosis or occlusion (85%) of the affected vessel, aneurysm 
formation (2%) or both (13%). Approximately 20% of patients have a monophasic and 
self-limited disease. TA in children tends to have a more aggressive course. One series41 
have shown a mortality rate as high as 35–40% by five years. 
 
 
Prognosis: 
 
Survival is worse by 1/6th in those with hypertension as this may cause cardiac failure, 
stroke & renal failure. The experience from India1 suggest that the cumulative survival at 
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five years after disease onset was 91%, after 10 years the figure was 84%, whereas event 
free survival figures were 74.9% and 64%, respectively. The main cause of death is 
cardiac failure secondary to hypertension or aortic regurgitation. Forty percent of deaths 
in the Indian cohort were the result of CHF1.  Presence of a severe single complication 
(group 2B) or multiple complications (group 3), severe hypertension, cardiac 
involvement, and severe functional disability are useful in predicting premature death, 
premature event, or both on follow-up. Patients with none of these factors have a good 
long-term prognosis. 
 
 
 
Natural history and clinical classification of occlusive thromboaortopathy (Takayasu's disease).  P = 
prognosis. 
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Plot of actuarial survival and event free survival curves1 after the A) onset of aortoarteritis   B) diagnosis of 
aortoarteritis   
         
Clinical imaging in TA 
 
Considerable advances have been made in recent years in vascular imaging. Thus 
magnetic resonance imaging and angiography (MRI/MRA), computed tomography (CT) 
and CT angiography, positron emission tomography (PET), CT-PET and high-resolution 
ultrasound (US) are becoming more widely available for the investigation of patients 
presenting with symptoms suggestive of a large vessel vasculitis22 
 
Conventional angiography 
Percutaneous intravascular angiography has been the gold standard investigation for the 
diagnosis of TA, providing high quality images of the arterial lumen. Lesions often occur 
at or close to the point of origin of the primary branches of the aorta. Localized 
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narrowing or irregularity of the arterial lumen is the earliest lesions detectable by 
angiography, and these may proceed to stenosis or complete occlusion. Vessels may also 
be dilated or aneurysmal—either saccular or fusiform. One of the most characteristic 
angiographic findings is the presence of ‘skip lesions’, where stenoses, or less frequently 
aneurysms, alternate with segments of uninvolved blood vessel. Based on the location of 
vessel involvement, a five-type angiographic classification system was introduced.  It is 
also important to note that intra-arterial angiography allows accurate assessment of 
central aortic pressures and imaging of the coronary arteries, which are not readily 
available with current non-invasive approaches23.  
 
Limitations of angiography:  Despite its benefits, intraarterial angiography is invasive, 
may aggravate local disease and only provides data on luminal anatomy. This inability to 
evaluate changes in the arterial wall may result in a normal angiogram in patients with 
early phase disease. Furthermore, the nature of the procedure and the necessity for 
exposure to contrast media and radioactivity significantly limits its use as a tool for 
monitoring patients with TA.  
 
Magnetic resonance imaging 
Increasing use is being made of MRI/MRA in the diagnosis and management of TA. The 
combination of multiplanar cardiac MRI using T1- and T2-weighted sequences in coronal 
and oblique sagittal planes, combined with contrast-enhanced 3D MRA 
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has been reported to display equivalent diagnostic accuracy to invasive angiography. A 
specialized MR unit with a dedicated study protocol can provide a highly informative 
arterial survey of the vessels typically involved in TA including pulmonary arteries24, 25  
  
Limitations of MR: MR remains time-consuming, operator-dependent and expensive. 
Furthermore, although MRI may reveal signs suggestive of vascular inflammation 
in TA, including arterial wall thickening, increased signal intensity and arterial wall 
oedema , no consistent correlation with disease activity or progression has been 
demonstrated . Although MR identified vessel wall oedema in 94% of patients with 
definite active disease and in 56% of those with apparent clinical remission, a consistent 
correlation between the oedema and disease progression could not be demonstrated26. It 
has also been reported that MR may occasionally overestimate the degree of stenosis in 
branch arteries, and that limitations in resolution may result in relatively poor imaging of 
distal aortic branches 
 
High-resolution Doppler ultrasound (US) 
Although widely available, the use of high-resolution Doppler US is relatively under 
investigated in TA. US may lead to an earlier diagnosis in patients presenting with TA, 
through detection of pre-stenotic lesions in the common carotid and subclavian arteries. 
US is particularly good for the assessment of common carotid arteries, where it is up to 
10-fold more sensitive than MRI, displaying a resolution of 0.1–0.2mm27.  In addition, 
Doppler US can be used for indirect measurement of arterial stiffness, which is 
commonly raised in patients with TA.  
 29 
 
Sonographic findings can be divided into the following28: -  
(i)Wall Thickening: This is the earliest finding in TA and is universally seen in all 
patients with aortoarteritis. There is uniform thickening of the wall of the vessels 
involved. The earliest wall thickening is seen in the SCAs, most commonly the left SCA. 
The arch of the aorta is also involved early; however, because of difficulty in 
visualization of the aortic arch, the presence of aortoarteritis is inferred from assessment 
of the major aortic arch branches. It is easier to assess the abdominal aorta and its 
branches. Measurement of abdominal aortic wall thickness is difficult because of the 
constant motion. In TA, long segments of diffuse, homogeneous, moderately echoic 
circumferential vessel wall thickening are found. This is seen more commonly in the 
CCA in TA and has been described as the “macaroni sign”. It can be distinguished from 
arteriosclerosis, which is more inhomogeneous. 
An increase in wall thickness is associated with secondary signs such as decreased 
pulsatility and loss of a normal triphasic flow pattern. The involved vessels reveal loss of 
the triphasic pattern, with a monophasic or biphasic parvus tardus type of spectral flow 
pattern.  This type of pattern is also seen distal to an occlusion when there is reformation 
of vessels by collaterals, but wall thickening associated with dampened flow suggests the 
diagnosis of TA.  
(ii)Luminal Narrowing or Stenosis: Luminal narrowing or stenosis is common in TA 
because of wall thickening, which leads to a decrease in the luminal diameter. This 
stenosis or narrowing is commonly seen as a long segment compared with atherosclerosis 
or fibromuscular dysplasia, in which the stenoses are commonly short segments.  
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(iii) Luminal Dilatation and Aneurysms: Luminal dilatation and aneurysms are not as 
common as narrowing. It is suggested to be due to inadequate supportive fibrous tissue or 
focal intima weakness. The aorta is most commonly affected, especially the thoracic and 
abdominal portions. 
(iv) Calcification: Calcification is uncommon in aortoarteritis and more commonly seen 
in atherosclerosis.  
(v) Occlusions: Occlusions are seen in the later stages of the disease 
In TA, the typical lesion identified by US is a long, smooth, homogeneous concentric 
thickening of the arterial wall, whereas in contrast an atherosclerotic plaque is shown to 
be nonhomogeneous, often calcified and associated with an irregular vessel wall. 
Comparative studies have shown that results obtained with US correlate closely with 
angiography and MRA, with agreement in excess of 95% reported27. In addition, US may 
on occasion be more sensitive than angiography, through its ability to detect the intimal-
media thickening associated with early lesions. The high resolution of Doppler US raises 
the possibility that it may also offer a means by which disease activity and response to 
treatment can be monitored22.  
 
Limitations of Doppler US imaging: Doppler US is highly operator-dependent and few 
centres have radiologists with sufficient vascular expertise. Furthermore, while imaging 
is optimal in the common carotid and vertebral arteries, assessment of the proximal 
subclavian and distal internal carotid arteries is limited by overlying tissues, and high-
resolution US of the aorta is not yet available. As with the other forms of non-invasive 
imaging, US do not allow measurement of central aortic pressures. Finally, there is 
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insufficient data available to conclude whether or not US has a place in disease 
monitoring. 
 
CT angiography 
CT angiography has been used to assess patients with TA. CT allows detection of arterial 
wall thickening in the pre-stenotic phase and can help distinguish TA from 
atherosclerosis30. CT compared well with angiography in the analysis of lesions in the 
common carotid, subclavian and brachiocephalic arteries. However, there are insufficient 
data in the literature to decide whether CT has a place in disease activity monitoring, with 
conflicting results reported for the use of arterial wall enhancement as a means of 
analysis. Likewise, contrasting results have been reported for the use of CT in assessing 
changes in wall thickness following treatment. 
 
Limitations of CT angiography: The main limitations associated with CT are the 
requirement for iodinated contrast administration and radiation exposure. The current 
resolution of CT is such that it is most effective in the assessment of the aorta and its 
proximal branches and offers relatively limited imaging of distal aortic branches 
 
18F-Fluorodeoxyglucose positron emission tomography 
Labelling of the glucose analogue deoxyglucose with Fluorine-18, a positron-emitting 
radionuclide, permits the identification of areas of high glucose metabolic activity. FDG 
uptake is related to both the metabolic rate of the cell and the abundance of glucose 
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transporters and although phosphorylated by hexokinase, FDG is not metabolized. The 
use of 18F-FDG-PET in pathology has been most widely studied in oncology. However, 
FDG uptake may also be increased at sites of inflammation and infection and although 
not as well characterized, 18F-FDG-PET is increasingly recognized to be a useful 
imaging modality in this setting. In TA, abnormal 18F-FDG-PET uptake is seen in the 
wall of large vessels (>4 mm), if vascular inflammation is present22.  In two recently 
reported retrospective studies which explored the utility of 18F-FDG-PET scanning in 
TA, this test had a sensitivity of 92% and a specificity of 100%, with a positive predictive 
value of 100% and a negative predictive value of 85%31. The second study32, comparing 
angiography, MRI and 18F-FDG-PET in six TA patients, suggested that 18F-FDG-PET 
is an important new clinical tool for the diagnosis of TA and that it may have a place in 
the monitoring of disease activity and response to treatment31. The principle advantage of 
18F-FDG-PET is its ability to detect pre-stenotic disease in patients presenting with non-
specific features commonly associated with early TA. Reduction in 18F-FDG-PET 
uptake at the site of aortitis has been correlated with both clinical improvement and a 
reduction in aortic wall thickness. In addition, a marked reduction in 18F-FDG-PET 
uptake at sites of inflammation following adequate immunomodulatory therapy has been 
demonstrated.  Studies have made observations suggesting that 18F-FDG-PET scanning 
represents a sensitive means for the detection of persistent disease activity, in those 
patients who appear clinically to be in remission while having histological evidence for 
persistent vascular wall inflammation. Compared with disease activity assessed by the 
NIH criteria, F-18 FDG PET-CT had a sensitivity of 78% and a specificity of 87% to 
detect active disease33. The sensitivity of F-18 FDG PET-CT for detecting active disease 
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was higher in patients with higher erythrocyte sedimentation rate values. Although the 
specificity of F-18 FDG PET-CT was high, owing to the low sensitivity of the NIH 
criteria in detecting active disease, further prospective studies are needed. 
 
Limitations of 18F-FDG-PET: First, it results in significant radiation exposure, is 
expensive and is limited to relatively few centres. Second, it lacks both histological 
confirmation of the findings in TA and a reliable standardized technique for 
quantification. Finally, 18F-FDG-PET may detect atherosclerosis, although this is 
more commonly seen in older patients and typically exhibits a vascular distribution 
distinct from TA. For example, TA typically affects the common carotid arteries while 
atherosclerosis is more typically seen in the internal carotid arteries. Moreover, an intense 
linear uptake of FDG is more characteristic of active vasculitis. Nevertheless, particularly 
in older TA patients it may prove difficult to distinguish between FDG uptake due to 
active TA or subclinical atherosclerosis.  
As yet, 18F-FDG-PET scanning has only been shown to be of use in the diagnosis of TA. 
Prospective studies are required to confirm its utility as a tool for the assessment of 
disease activity and for monitoring. Likewise, data are needed on the outcome of patients 
whose 18F-FDG-PET scan suggests persistent disease activity, so as to establish whether 
they are more likely to suffer a disease flare or to develop progressive vascular lesions. 
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Assessing the disease activity in Takayasu arteritis 
 
Activity of disease is the presenting manifestation in about 1/3rd of cases of aortoarteritis. 
About 10% of cases have activity throughout the course of the disease. Constitutional 
symptoms of fever, night sweats, malaise, headache, polyarthralgia or weight loss have 
been reported in 7 - 36% cases of active disease34.  Detailed assessment of disease extent 
and activity are essential to follow both the long term outcome and the response to 
therapy in TA. Clinical analysis of TA disease activity, response to treatment and 
detection of relapse however, remains suboptimal. 
 
1. Acute phase reactants as markers of disease activity: 
 
Several studies have examined the acute phase response in Takayasu arteritis. Elevated 
erythrocyte sedimentation rate (ESR > 40mm in 1 hour) is considered as an indicator of 
active disease with or without constitutional symptoms like fever, polyarthralgia35. 
Mandalam et al in 1994 suggested that a persistently elevated ESR of more than 40mm in 
1 hour is an indicator of disease activity, inflammation and disease progression36. 
Ishikawa20 found that the erythrocyte sedimentation rate (ESR) was raised in 29 of 54 
patients studied, with an equal distribution in the four disease categories. He suggested an 
ESR of > 20mm in 1 hour as an index of activity. Higher values were seen in the younger 
patients, declining with age, perhaps representing the natural history of the disease. Hall 
et al4 found that the ESR was raised in three quarters of 32 cases, and that it showed an 
excellent correlation with treatment effect. However, Kerr et al37 concluded that the ESR 
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was not a consistently reliable marker of disease course, being raised in 72% with active 
disease but also in nearly half of patients in clinical remission. In their study, 44% of 
arterial biopsy specimens obtained from patients with clinically inactive disease 
demonstrated vasculitis, suggesting that disease activity may be underestimated. 
This inconsistency has led to a search for better serological markers.  
A study reported in 199838 concluded that no known serological test was able to supplant 
vascular histopathology in determining disease activity. This study compared 29 patients 
(22 with clinically inactive disease and seven with clinically active vasculitis) with 26 
healthy control volunteers; no serological test reliably distinguished healthy volunteers 
from patients with active disease. The markers assessed included ESR, C reactive protein 
(CRP), tissue factor, von Willebrand factor, thrombomodulin, and tissue plasminogen 
activator, in addition to various adhesion molecules. The numbers with clinically active 
disease were small and again may have been underestimated in the absence of 
histological assessment. ESR and CRP values were not directly compared. Although 
disease activity may not be discriminated by these markers at a single point in time, for 
individual patients the use of a given parameter longitudinally may still be of value. 
 
 
2. Cytokines & Matrix MetalloProteinases (MMPs) as markers of disease activity 
 
Serum concentrations of the pro-inflammatory and chemotactic cytokines interleukin 1b 
(IL-1b), IL-6, and RANTES (regulated on activation, normal T cell expressed and 
secreted) have been assessed by enzyme linked immunoabsorbent assay. All of 18 
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patients studied39 had increased concentrations of IL-6 and RANTES during active 
disease compared with healthy controls, and concentrations parallelled disease activity. 
These cytokines correlated with the ESR but not with CRP values. This lack of CRP 
correlation (CRP being driven by IL-1 and IL-6) was not adequately explained. The 
positive correlation with disease activity suggested that these cytokines may contribute to 
the vasculitis and raised the possibility of their use in monitoring disease and treatment. 
However, serum cytokine assays are not necessarily a reflection of tissue cytokine 
concentrations and may not accurately detect biologically active cytokine. Their use over 
and above the ESR remains to be established. Interleukin-18 levels were also found to 
correlate well with disease activity40 & may prove to be a useful marker for monitoring 
treatment response.  
 
In TA, the earliest change appears to be a granulomatous inflammation in the adventitia 
and outer layers of the affected arteries, followed by gradual progression to a panarteritis 
with inflammatory mononuclear cell infiltration. Histologically this is characterized by 
degeneration of the elastic lamella in the media of affected elastic arteries. The process 
eventually produces intimal thickening and scarring, and aneurysms form in the 
weakened arterial walls, particularly when the aorta itself is involved. In this process, 
proteases secreted from infiltrated cells are thought to play some role in the destruction of 
elastic fibers. Among the types of elastolytic proteinases, matrix metalloproteinases 
(MMPs) can be induced in response to cytokines implicated in a variety of inflammatory 
processes. MMPs comprise a family of calcium-dependent zinc endoproteinases and 
might pathologically participate in a variety of inflammatory responses. MMP-2, also 
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known as 72-kDa gelatinase, which can digest gelatin, type IV collagen, and elastin, is 
constitutively expressed in mesenchymal cells such as fibroblasts and smooth muscle 
cells. MMP-2 levels were higher in patients with TA than in healthy controls, regardless 
of disease activity, and that a high concentration of MMP-2 was helpful in diagnosing 
TA. MMP-3, also known as stromelysin A, is secreted mainly by fibroblasts and smooth 
muscle cells.12 MMP-9, or 90-kDa gelatinase, is produced by mononuclear cells, 
including neutrophils, macrophages, and T lymphocytes. Cytokines, including 
interleukin-6 and RANTES, which can accelerate the production of MMP-3 by 
mesenchymal cells and of MMP-9 by inflammatory cells, are secreted in inflammatory 
conditions and are reported to increase in patients with active-phase TA. A positive 
correlation was observed between both MMP-3 and MMP-9 levels and disease activity 
score, and the elevated levels of MMP-3 and MMP-9 improved when patients entered 
remission41. In addition, serum levels of TIMP-1 tissue inhibitor of metalloproteinase-1 
(TIMP-1) were lower in TA patients than those in controls. The highest sensitivity and 
specificity were 800 and 100 ng/mL for MMP-2 and MMP-3, respectively. With these 
values, the sensitivity and specificity were 96% and 100%, respectively, for MMP-2 as a 
diagnostic marker and 91% and 100%, respectively, for MMP-3 as a disease activity 
marker. As to MMP-9 as an activity marker, cutoff values of 90 and 75 ng/mL gave 
sensitivity and specificity of 45.5% and 100%, respectively, and 63.6% and 81.8%, 
respectively41. In this respect, MMP-3 is a more suitable marker for disease activity than 
MMP-9, but the combination of MMP-3 and MMP-9 may allow us to estimate more 
accurate disease activity. Higher MMP-3/TIMP-1 ratios than in patients with remission 
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were also found in active TA. Thus, MMP-3/TIMP-1 ratio may also be a useful marker 
for disease activity41. 
 
3. National Institute of Health (NIH) criteria for disease activity:  
 
By this, if 2 or more of the following features were present, the disease was considered to 
be active.  
 (1) Presence of systemic features/ constitutional symptoms such as fever, arthralgia, or 
musculoskeletal problems with no other cause identified;  
(2) Elevated ESR;  
(3) Presence of features of vascular ischemia or inflammation, such as claudication, 
diminished or absent pulse, bruit, vascular pain (carotodynia), or asymmetrical blood 
pressure in either upper or lower limbs (or both), and  
(4) Typical angiographic features. 
.New onset or worsening of each of the above-mentioned features was given a score of 1; 
a score of 2, 3, or 4 defined active disease37.  Although this is the most commonly used 
score for assessing disease activity in TA, the nonvalidated status43 & the low 
sensitivity33 of the NIH criteria in detecting active disease is a matter of concern. The 
requirement for an angiographic examination also makes it cumbersome.  The 
invasiveness and cumulative radiation toxicity of this procedure limit its use in 
monitoring disease progression. 
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4. Indian Takayasu Activity Score (ITAS) to assess disease activity: 
 
The Birmingham Vasculitis Activity Score (BVAS), a reliable indicator of disease 
activity for primary systemic vasculitis, lacks sensitivity for the large vessel vasculitides 
and is rarely useful for clinical practice. The main problem here is assessing activity in a 
disease where so much of the pathology is located in deep-seated vessels, progressing at a 
slow pace and not necessarily associated with any acute phase response. The need is to 
develop techniques that will allow activity to be assessed independently of acute clinical 
events, such as vessel occlusion. The standard tools, BVAS and Vasculitis Disease Index 
(VDI), do not perform well for the different disease pattern in TA where there is no 
simple test for disease activity44. 
 
At the Third International Conference on Giant Cell Arteritis and Polymyalgia 
Rheumatica held in Cambridge in July 2005, Dr Sivakumar, on behalf of the IRVAS 
group, presented a new clinical index of disease severity and extent in TA (the DEI-
TAK) which uses the BVAS index as its template45.  This DEI-TAK index is based on 
the findings from 143 Indian patients with Takayasu arteritis and contains 59 items in 11 
organ-based scoring systems with emphasis on the cardiovascular system (19 items). The 
data sheet also includes an acute phase test and the physicians’ global opinion on activity. 
It was in use to determine the extent and pattern of disease seen by rheumatologists in 
India. The DEI-TAK was revised by M.R Sivakumar, R.Misra, and P.A.Bacon in Sept 
2007 and applied in patients with TA, as the Indian Takayasu Activity Score (ITAS). 
Each item is scored only if the abnormality is new or worse, within the past 3 months.  
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An ITAS score more than or equal to 3 suggest active disease.  
 
The new Indian Takayasu Activity Score (ITAS) was validated44 in a single referral 
centre where one investigator scored 177 patients and in a group exercise where 10 
experienced physicians scored both paper and live cases. The ITAS score of recent 
disease, showed a strong correlation with the PGO (physicians’ global opinion of disease 
activity). In the large series, the mean ITAS score in 13 ‘‘active’’ cases was 5.9; in 
grumbling disease (n= 45) the score was 3.2; in inactive disease (n= 36) the score was 0.9 
(p < 0.000 by Anova). In the group exercise, ITAS intra-class correlation coefficient was 
0.754 (p<0.000). ITAS again correlated significantly with PGO scored on a 10mm 
analogue scale across the range (r= 0.502, p<0.000). ITAS also had a strong correlation 
with BVAS (r= 0.578, p<0.000) but is a more sensitive assessment tool for TA41. An 
elevated ESR/CRP was associated with systemic disease but did not relate to any other 
score items.  The DEI.Tak used to score relevant items occurring since the onset of 
disease provides a comprehensive damage index which confirmed the different disease 
pattern observed in TA in the large cross-sectional study. The authors concluded44 that 
ITAS provides an index of activity that correlates with PGO and BVAS, and can be used 
in therapeutic studies in centres where cost restricts the use of MR and PET scans. 
However the DEI.Tak provides a useful tool for longer term outcome and 
epidemiological studies. 
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5. High resolution Doppler Ultrasound of Common Carotid arteries 
 
The use of high-resolution doppler UltraSound (US) is relatively under investigated in 
TA. US is particularly good for the assessment of common carotid arteries, where it is up 
to 10-fold more sensitive than MRI, displaying a resolution of 0.1–0.2mm27. In addition, 
Doppler US can be used for indirect measurement of arterial stiffness, which is 
commonly raised in patients with TA45.  The high resolution of Doppler US raises the 
possibility that it may also offer a means by which disease activity and response to 
treatment can be monitored.  
 
Park and colleagues studied the common carotid artery and based on the ESR, CRP and 
CT angiography findings they graded lesions identified active or inactive47.  Using high-
resolution US they report a common carotid arterial wall thickness of 2.5–5.0mm in 
active lesions compared with 1.1–2.0mm in lesions considered inactive, corresponding to 
a vessel diameter of 10mm or more in active disease and <7mm in inactive disease. 
Hence, they suggest that US may represent a means by which TA disease activity can be 
monitored. In addition, US has identified reductions in arterial wall thickness in response 
to treatment and following resolution of disease activity. However, although US is the 
most sensitive noninvasive method for detection of abnormalities in the common carotid 
arteries48, further prospective studies are required to show convincingly that it can be of 
use in estimating disease activity and outcome. 
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6. Carotid Intimal-Medial Thickness (CIMT) as a marker of disease activity  
 
A variety of methods are available for the assessment and imaging of vascular disease, 
with varying degrees of sensitivity. Central atherosclerosis is often measured with high-
resolution carotid ultrasound for the presence of plaque, though the extent of carotid 
artery intima–media thickness (CIMT) conveys different, though possibly just as 
important, information. B-mode ultrasound is a safe, reliable and non-invasive method of 
measuring CIMT. The combined thickness of the intima and media can be measured in 
various sections of the carotid artery, although the common carotid artery appears to be 
the most reproducible and accurate area to assess. This is usually measured 1 cm below 
the bifurcation of the common carotid in order to accurately reassess the same area. The 
internal carotid is technically more difficult to assess but appears to correlate more 
closely with major atherosclerosis risk factors and pre-exisiting cardiovascular disease. 
 
An increase in CIMT has been shown to correlate with cardiovascular risk factors such as 
smoking, high cholesterol and hypertension49. It has also been shown to be an 
independent predictor for subsequent myocardial infarction and stroke51. 
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In addition, various studies have shown an increase in CIMT in inflammatory joint 
conditions such as RA and psoriatic arthritis51, 52, along with other inflammatory 
conditions such as Behcet’s disease and Takayasu’s arteritis53, 54. There is emerging 
evidence that smoking influences CIMT in RA and that treatment with anti-tumour 
necrosis factors may have a beneficial effect on CIMT measurements. This suggests that 
these treatments may reduce cardiovascular risk. In the future, CIMT measurements 
could be used to assess cardiovascular risk of patients with rheumatic disease54. 
 
 Amongst the parameters of vascular change, distensibility is sometimes quoted, 
presumably because it is easily visualized, which may or may not be synonymous with 
the more frequently described arterial stiffness, usually accepted to be impaired. There is 
sometimes a lack of clarity as to whether this is a primary phenomenon of rheumatic 
disease or a secondary consequence of cardiovascular disease once present. A consensus 
would accept, however, that arterial stiffness is increased in most chronic inflammatory 
diseases including not only post-menopausal females with RA but also in adolescents and 
young adults with SLE. Sometimes this may be site specific, and in RA it can be reduced 
by atorvastatin, particularly in patients with the most severe disease.  Arterial stiffness 
can also be enhanced in vasculitis, including both Takayasu’s arteritis43and giant cell 
arteritis. 
 
Lande et al55 report the first study of CIMT in hypertensive adolescents that corrects for 
the effects of body mass. They found that CIMT was greater in hypertensive subjects than 
in controls matched for age, gender, and BMI. Gonzalez et al56 demonstrated that CIMT 
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measurements in young adults were 2.2%–3.1% greater in the right carotid artery than in 
the left.  He suggested that the reproducibility of CIMT measurements is greatest when 
combining values from both carotid arteries and/or from the maximal and minimal 
arterial diameters. 
 
 Zienlinski et al57 in their study of ultrasound examination of carotid arteries with intima 
media measurement in 18 patients (16 women and 12 men, aged 11-62) demonstrated 
that the mean IMT of the CCA in patients with Takayasu’s disease was significantly 
higher than in controls(mean +/- SEM; 1.1+/- 0.1 vs 0.59  +/- 0.01mm). In healthy 
controls, the intima media thickness of the bulb was higher than that in the CCA (0.7 +/- 
0.05 as 0.59 +/- 0.01).In patients with Takayasu’s disease, that proportion was inversed 
(0.81 +/- 0.05 as 1.1 +/- 0.1mm). Higher intima media thickness found in the common 
carotid artery than in the bulb can raise a suspicion of Takayasu’s arteritis.   
 
Seth et al evaluated common carotid artery carotid intima–medial thickness (CCA–IMT) 
in 56 common carotid arteries (CCAs) in 28 healthy controls and 74 CCAs in 37 patients 
of TA58.  They correlated these findings with the presence of activity as assessed by the 
National Institutes of Health (NIH) criteria. CCA–IMT was increased (> 0.8 mm) in 59% 
of the patients with TA. In patients with disease activity, the CCA–IMT was more than in 
those without activity (1.5 ± 0.16 vs. 0.9 ± 0.2 mm, P < 0.005). This is presumably 
because of ongoing inflammation causing abnormal thickening. Even among patients 
without active disease, CCA–IMT was more than in controls (0.9 ± 0.2 vs. 0.6 ± 0.1 mm, 
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P < 0.05) possibly due to a milder degree of inflammation or healing with fibrosis. All 
patients with angiographic carotid obstruction had increased CCA–IMT irrespective of 
whether they were active or not. However, in patients with angiographically normal 
carotid arteries, CCA–IMT was increased only among the patients who were active 
(1.4 ± 0.2 vs. 0.7 ± 0.04, P < 0.05). Abnormal CCA–IMT as marker of disease activity 
had a sensitivity of 82% and specificity of 60%. On excluding patients with increased 
CCA–IMT who had angiographic carotid stenosis (because the increase in CCA–IMT 
cannot be attributed entirely to activity alone in these patients), the specificity increased 
to 70%. They concluded that increased CCA–IMT is a reliable marker of active disease, 
especially in the absence of angiographically visible carotid disease58.  
 
Measurement of CIMT - Technical Considerations:  
 
CIMT imaging requires methodic attention to carotid anatomy, ultrasound parameters, 
and a standardized measurement protocol. To begin the CIMT examination, the patient 
should be supine with the sonographer positioned at the head of the bed. The patient and 
sonographer should be comfortable during the examination with careful attention paid to 
safe, efficient, and ergonomic scanning positions to minimize the potential for injury. 
During the scan the patient should have minimal support under the neck to aid in neck 
extension and rotation that will aid in positioning of the carotid artery for optimal 
imaging. Linear-array transducer frequency is best between 8 to 12 MHz using 
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fundamental frequency only50.  The far wall CIMT should be seen as a double line 
representing the lumen-intima and media-adventitia interface. The best image resolution 
is obtained when the ultrasound beam is perpendicular to the structure being imaged, 
which may require the sonographer to manipulate transducer, ie, heel-to-toe and/or 
rotation motions, to optimize the intima-media image. 
 
Reliability and Reproducibility 
 
The difference in thickness between a normal scan and an abnormal scan can be small 
and a common concern for those who have not previously performed CIMT measurement 
is whether the measurement is accurate and reproducible. Data from published research 
centers that have an expertise at performing CIMT have consistently shown that the 
measurement is highly reproducible, although this varies somewhat depending on sites 
measured, number of measurements, and whether mean or maximum values were used50. 
Newer semiautomated border detection programs are available that are less time-
consuming and more reproducible for less experienced users. A recent study compared a 
novice reader with a reference laboratory using a semiautomated border detection 
program. The novice reader results were bioequivalent to the reference laboratory with 
small absolute differences (experienced 0.011 ± 0.004mm, novice 0.022 ±0.004 mm) in 
CIMT and high reproducibility (coefficients of variation: experienced 3.1%, novice 
7.8%)59. 
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Reproducibility of 2 major carotid intima-media thickness studies50:  
Study Reproducibility 
Rotterdam study SD between paired measurements of sonographers, & 
readers were -0.004 & 0.066. 
Atherosclerosis Risk in 
Communities Study 
Between - reader reliability coefficients ranging from 0.78 
to 0.93 & coefficients of  variation ranging from 13.1% to 
18.3% 
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DESIGN & METHODOLOGY 
 
 
Study design: 
An observational study done in the department of Cardiology, CMCH, Vellore 
 
Methodology: 
 
Study Protocol 
All consecutive patients with Takayasu Arteritis (TA) seen in the Cardiology department 
from August 2008 to January 2010 were enrolled in the study.  Diagnosis was based on 
the American College of Rheumatology (1990) ACR criteria. Disease activity was 
assessed using (i) acute phase reactants- ESR, CRP (ii) NIH (National Institute of Health) 
criteria, & (iii) ITAS score (Indian Takayasu arteritis Activity Score) at enrollment.  
CIMT was measured in all these patients. Angiographic extent of the disease including 
involvement of the common carotids was also assessed at enrollment. 
CIMT was also measured in 30 healthy controls, of a similar age group but with no 
evidence of systemic hypertension, diabetes mellitus, peripheral vascular disease or 
coronary artery disease.  
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CIMT measurement in the study 
CIMT images were acquired with a high-end ultrasound system (iE-33) with an L 11–3 
(Linear Array, 288 elements, 11.0 to 3.0 MHz) transducer (Philips Medical Systems). 
Patients were placed in a supine position using a 45° head rotation angle for acquisition. 
Acquisitions were obtained in a zoomed still frame at end diastole and images were stored 
digitally for off-line analysis. Long-axis images and cross-sectional images of the right 
and left common carotid artery were obtained with posterior, medial, and anterior 
transducer angulations. CIMT was measured on the fall wall of the right and left common 
carotid artery from long-axis images obtained with medial transducer angulation. CIMT 
were measured in the proximal, mid & distal common carotid artery on both the left & 
right side. The maximum diameter at sites where there was no plaque seen was measured. 
The means of the three CIMT values of the right & left common carotid artery were 
calculated separately. The CIMT value used for analysis in each patient was defined as 
the average of the mean CIMT of the right and left common carotid arteries. CIMT 
measurements were performed by the same sonographer who was unaware of the activity 
status of the disease at the time of measurement. 
 
Outcome measures:  
CIMT & its correlation with disease activity, in the whole group of patients with TA was 
the primary outcome measured.  Demographic profiles, angiographic pattern of 
involvement, correlation of CIMT with angiographic involvement of  carotid arteries 
were the secondary outcomes measured. 
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Statistical analysis: 
 
Statistical analysis was done using SPSS Version17. Continuous variables were 
expressed as mean ± standard deviation. Continuous variables with skewed distributions 
were expressed as median and interquartile range. Distributions of CRP and ESR were 
skewed with a Galton’s (log-normal) distribution. Hence they were analyzed on a log 
scale to obtain normal distribution. Categorical variables were expressed as counts 
(percentages) unless stated otherwise. Mann–Whitney U test. Differences between groups 
were compared using the Mann-Whitney U-test (non parametric) and t test (parametric) 
wherever appropriate. In brief, for groups with smaller sample sizes and non normal 
distribution, MannWhitney test was used and for groups with larger sample sizes with 
normal distributions, t test was used. For categorical variables, Mantel-Haenszel chi-
square was used to test the significance of the linear relationship between two ordinal 
variables. Pearson’s chi-square and Fisher exact tests were used, wherever appropriate, 
for comparison of categorical variables. Pearson and Spearman Rank Coefficient 
correlations were used wherever appropriate to measure of the strength of the 
associations between two variables. Using NIH and ITAS criteria as the gold standard, a 
sensitivity analysis of CIMT was performed. A ROC ("Receiver Operating 
Characteristic") curve was drawn to estimate the cut-off point for CIMT as a predictor of 
disease activity. All tests used were two-tailed and the p<0.05 value was considered 
statistically significant. 
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RESULTS 
A total of 41 patients were studied. Out of this, angiographic data was available for 39 
patients. Majority (75.6%) of the study population were females, in keeping with the 
pattern seen in TA. The male, female ratio was approximately 1:4. The baseline 
characteristics were as shown in Table 1.  All the variables except CRP had a normal 
distribution pattern. Hence these were expressed both in the Mean ±SD & Median + 
Interquartile Range. Owing to the distribution pattern of CRP, the mean & median values 
were widely apart. The blood pressure recorded was the central aortic pressure.  
 
Table 1: Baseline characteristics 
Variable Mean ±SD Median + IQ Range 
Age (years) 29 ±12 27 (22-34) 
Female Sex * 31 (75.6) 
ESR (mm/hour) 35.46±27.26 30 (15-50) 
CRP (mg/l) 14.03±15.87 7.69 (1.74-25) 
Systolic Blood Pressure 
(mmHg) 
142±27 142 (121-159) 
Mean Blood Pressure 
(mmHg) 
106±18 101 (95-113) 
*Expressed as number and percentages 
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Table: 2: Distribution of NIH scores in the study population 
NIH 
Score 
Frequency Percent Cumulative 
Percent 
0 12 29.3 29.3 
1 14 34.1 63.4 
2 13 31.7 95.1 
3 2 4.9 100.0 
Total 41 100.0  
 
 
Table: 3 Distribution of ITAS scores in the study population 
ITAS 
Score 
Frequency Percent Cumulative 
Percent 
0 4 9.8 9.8 
1 2 4.9 14.6 
2 14 34.1 48.8 
3 2 4.9 53.7 
4 8 19.5 73.2 
5 2 4.9 78.0 
6 3 7.3 85.4 
9 1 2.4 87.8 
11 3 7.3 95.1 
12 2 4.9 100.0 
Total 41 100.0  
 
Table 2 shows that by NIH criteria, 15 patients ie 36.6% had active disease. Table 3 
demonstrates that when ITAS scoring was used to define active disease, 21 patients ie 
51.2% had active disease.  
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Table 4a: Distribution of angiographic types in the study population 
 Frequency Percent 
I 11 26.8 
IIa 2 4.9 
III 2 4.9 
IV 7 17.1 
V 17 41.4 
n/a 2 4.9 
Total 41 100.0 
 
 
Table 4b:  
Distribution of angiographic types among men & women in the study population 
Angiographic 
type 
SEX Total 
 Female Male 
I 10 1 11 
IIa 0 2 2 
III 1 1 2 
IV 5 2 7 
V 14 3 17 
n/a 1 1 2 
Total 31 10 41 
 
By the angiography, the most common was type V (41.4%) followed by I (26.8%) & then 
type IV (17.1%). The arch vessels were involved in 62.85% of the cases whereas the 
infra-diaphragmatic abdominal aorta was involved in 51.21%. Extensive involvement of 
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the whole aorta & its branches were seen in 1 patient. There were no cases of type IIb 
disease. Coronary involvement was noted in 2 patients. Pulmonary angiogram was not 
done in these patients & hence the data regarding pulmonary artery involvement was not 
available. All the angiographic types except type III, which had an equal distribution, 
were more common in women than in men. Arch vessel involvement seems to be much 
more common in women than in men.  
 
Table 5:  CIMT values 
 
CIMT in the study population (n = 41) 
 Mean ±SD Median + IQ Range 
CIMT (Mean of both sides) 0.85 ± 0.30 0.83(0.60 – 0.98) 
CIMT (Left) 0.87 ± 0.37 0.80(0.60 – 1.09) 
CIMT (Right) 0.82 ± 0.33 0.71(0.58 – 0.96) 
 
 
 
CIMT in the control population (n = 30) 
 Mean ±SD Median + IQ Range 
CIMT (Mean of both sides) 0.50 ± 0.06 0.50(0.46 – 0.53) 
CIMT (Left) 0.50 ± 0.06 0.50(0.47 – 0.53) 
CIMT (Right) 0.51 ± 0.06 0.52(0.47 – 0.54) 
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Difference in the mean of two groups (Parametric- Independent samples t test) 
 Patients controls p 
CIMT 0.85 ± 0.30 0.50 ± 0.06 0.000 
 
CIMT was increased in patients with Takayasu arteritis as compared to the controls 
(Table 5). The mean CIMT among the study population was 0.85 ± 0.30. This was 
significantly more than that of the controls which was 0.50 ± 0.06 (p = 0.00). Moreover, 
as shown in Table 6, patients with an active disease (Mean ± SD = 1.05 ± 0.33) had 
higher CIMT values than those with inactive disease (Mean ± SD = 0.73±.20). By the 
non-parametric- Mann Whitney U test, the difference in the mean of two groups was 
statistically significant (p = 0.001).  
 
Table 6. CIMT in patients with active or inactive disease 
 Mean ±SD p value* Median + IQ Range 
Active  (n= 15) 1.05±0.33 0.001 0.98 (0.86-1.29) 
Inactive  (n= 26) 0.73±20 0.68 (0.58-0.89) 
Overall  (n = 41) 0.85 ± 0.30  0.83(0.60 – 0.98) 
* p value was obtained by the Non Parametric- Mann Whitney U test 
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Table7. Influence of Carotid Angiographic abnormality on CIMT 
 Normal Abnormal p 
CIMT, Right side 0.76± 0.29  (n = 32) 1.09±0.42  (n = 7) 0.037 
CIMT, Left side 0.81± 0.34  (n = 27) 1.05±0.39  (n =12) 0.037 
CIMT, Combined 0.79±0.31  (n = 59) 1.07±0.39  (n = 19) 0.002 
 
When all the carotid vessels in the study population were assessed together, 59 common 
carotid arteries (75.6%) had a normal carotid angiogram & 19 common carotid arteries 
(24.4%) had a normal carotid angiogram. Moreover, as in Table 7 the CIMT values were 
significantly higher in common carotid arteries with abnormal luminogram than in the 
ones with a normal angiogram.  
 
Table 8. Correlation of CIMT with age, ESR, CRP, ITAS & NIH 
 Pearson’s Correlation 
coefficient Rho(r) 
p 
CIMT log & CRP log 0.184 0.25 
CIMT log  & ESR log 0.301 0.05 
CIMT & Age 0.100 0.53 
CIMT & SBP -0.198 0.22 
CIMT & MBP -0.300 0.06 
CIMT & ITAS 0.506 0.001 
CIMT & NIH 0.559 0.000 
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Table 8a. Correlation of ITAS with NIH Score 
 Spearman’s Correlation 
coefficient Rho(r) 
p 
ITAS & NIH 0.548 0.000 
 
Analysis of correlations of mean CIMT with the different variables of disease activity – 
ESR, CRP, NIH & ITAS, (Table 8) showed that there was a moderate, statistically 
significant correlation with ESR, NIH & ITAS scores. The correlations with CRP, age & 
Blood pressure were however not significant. Correlation analysis as shown in Table 8a 
also showed a significant correlation between the 2 scores – NIH & ITAS.  
 
Strength of association of CIMT ≥ 0.80mm with the variables of disease activity were 
evaluated by the Mantel - Hansel linear by linear association chi square test. CIMT ≥ 
0.80mm was found to have a statistically significant association with ESR ≥ 40mm in 1 
hour (Table 9a), NIH score ≥ 2(Table 9c),  & ITAS score ≥ 3(Table 9d).  But the 
association with CRP was not significant (Table 9b).   
 
Table 9. CIMT association with markers of disease activity 
CIMT association with ESR, CRP, NIH & ITAS by the Mantel Haensel linear by linear 
association chi square test: -  
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Table 9a: 
 ESR Total 
< 40 ≥ 40 
 CIMT < 0.8 17 1 18 
CIMT ≥ 0.8 13 10 23 
Total 30 11 41 
p Value=0.007 
 
 
Table 9b: 
 CRP Total 
< 6 ≥  6 
 CIMT < 0.8 9 9 18 
CIMT  ≥ 0.8 10 13 23 
Total 19 22 41 
p Value=0.681 
 
 
Table 9c: 
 NIH Total 
< 2 ≥ 2 
 CIMT < 0.8 16 2 18 
CIMT ≥ 0.8 10 13 23 
Total 26 15 41 
P Value=0.003 
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Table 9d: 
 ITAS Total 
<3 ≥ 3 
 CIMT < 0.8 15 3 18 
CIMT ≥ 0.8 5 18 23 
Total 20 21 41 
P Value=0.000 
 
The strength of association was also tested in patients with angiographic arch vessel 
involvement. The result of this is shown in Table 10.  Even in these 27 patients, a 
statistically significant association was demonstrable between CIMT ≥ 0.80mm with  
ESR ≥ 40mm in 1 hour (Table 10a), NIH score ≥ 2(Table 10c),  & ITAS score ≥ 3(Table 
10d) but  not with CRP(Table 10b).   
 
Table 10. CIMT association with markers of disease activity, among patients with 
angiographic arch vessel involvement 
Table 10a 
 ESR Total 
< 40 ≥ 40 
 CIMT < 0.8 10 0 10 
CIMT ≥ 0.8 7 10 17 
Total 17 10 27 
P Value = 0.003 
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Table 10b 
 CRP Total 
< 6 ≥  6 
 CIMT < 0.8 4 6 11 
CIMT  ≥ 0.8 7 10 17 
Total 11 16 27 
P Value = 0.953 
 
 
Table 10c 
 NIH Total 
< 2 ≥ 2 
 CIMT < 0.8 10 0 10 
CIMT ≥ 0.8 6 11 17 
Total 16 11 27 
P Value = 0.001 
 
 
Table 10d 
 ITAS Total 
<3 ≥ 3 
 CIMT < 0.8 9 1 10 
CIMT ≥ 0.8 3 14 17 
Total 12 15 27 
P Value = 0.000 
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Table 11. Sensitivity(Sn) and specificity(Sp) of CIMT to detect active disease 
 
Gold Std CIMT measure Sn Sp LR (+) LR (-) PPV NPV 
NIH CIMT ≥ 0.80mm 86% 61% 2.20 0.23 0.57 0.88 
ITAS CIMT ≥ 0.80mm 86% 75% 3.44 0.19 0.78 0.83 
 
Sn: Sensitivity; Sp: Specificity;  
LR (+): Positive likelihood ratio;  LR (-): Negative likelihood ratio 
PPV: Positive Predictive Value;   NPV: Negative Predictive Value 
 
NIH criteria are one of the most commonly used criterions to assess disease activity or 
response to treatment in patients with TA. Hence using the NIH criteria as the gold 
standard to detect active disease, sensitivity(Sn) and specificity(Sp) of CIMT ≥ 0.80mm 
to detect active disease was calculated. Based on these likelihood ratios were also 
calculated, as shown in Table 11. Thus CIMT ≥ 0.80mm has a sensitivity of 86% & a 
specificity of 61% which increases to 86% & 75% when ITAS is used as the gold 
standard.  
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Table12. Influence of carotid angiographic abnormality on sensitivity and specificity 
of CIMT  
 
 Carotid Angiogram Total 
Normal Abnormal 
 
CIMT < 0.80mm 
37 3 40 
CIMT ≥ 0.80mm 22 16 38 
Total 59 19 78 
 
Sensitivity = 84%; Specificity = 63%; 
Positive Predictive Value = 0.42; Negative Predictive Value = 0.93 
Likelihood ratio for a Positive test = 2.27; Likelihood ratio for a Negative test = 0.253 
Thus as per Table 12, a CIMT ≥ 0.80mm in a patient with TA increases the pretest 
probability of having an abnormal carotid angiogram.   
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ROC analysis: 
ROC curve was generated to assess the best cut off point of CIMT that yields the best 
sensitivity & specificity to detect active disease.  This was done using both NIH & ITAS 
as the gold standard.  
Table 13. With NIH as gold standard: 
  
A mean CIMT of ≥ 0.82mm yields a sensitivity of 87% & a specificity of 65% and a 
mean CIMT ≥ 0.85mm yields a sensitivity of 80% & a specificity of 73%.   
 
AUC = 0.812;       
p = 0.001 
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Table14. With ITAS as the gold standard:  
 
 
By this, CIMT ≥ 0.82mm yield a sensitivity of 86% & a specificity of 80% and mean 
CIMT ≥ 0.85mm yield a sensitivity of 81% & a specificity of 90%.  
 
 
 
 
AUC = 0.889    
p = 0.000 
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Table 15. Using ROC data, best cut off points derived for CIMT were as below: - 
 
Gold Std   CIMT measure Sensitivity Specificity LR (+) LR (-) 
ITAS CIMT ≥ 0.82mm 86% 80% 4.3 0.5 
 CIMT ≥ 0.85mm 81% 90% 8.1 0.21 
NIH CIMT ≥ 0.82mm 87% 65% 2.5 0.002 
 CIMT ≥ 0.85mm 80% 73% 2.96 0.27 
 
This would mean that if ITAS is used as the gold standard to detect active TA, a CIMT ≥ 
0.85mm adds approximately 40% to the pretest probability of an active disease.  
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DISCUSSION 
Assessment of disease activity in TA is currently suboptimal. The currently accepted 
method is NIH criteria. This however has many limitations - the nonvalidated status40 of 
the score, the low sensitivity31& the need for an invasive angiographic study. Many 
serum markers of disease activity have been suggested by various clinical studies. Apart 
from the acute phase reactants which has a low specificity for TA, the others suggested 
include MMP-3/TIMP-1 ratio (Matrix MetaloProteinase – 3 / Tissue Inhibitor of 
MetalloProteinase – 1, ratio), Interleukin-18 levels, etc. newer imaging techniques like 
MRI, F-18 FDG PET scans & F-18 FDG PET-CT scans are promising in the diagnosis & 
assessment of disease activity in patients with TA.  However these tests are expensive & 
not easily available. It was in this setting that the ITAS scoring was proposed & 
subsequently validated in 1 study. The ITAS, a more sensitive assessment tool for TA 
than the BVAS scoring, involves 59 items in 11 organ-based scoring systems with 
emphasis on the cardiovascular system (19 items). By this scoring the disease is 
considered to be active if the score exceeds 2 and each item is scored only if the 
abnormality is new or worse, within the past 3 months. Hence at 1st visit or presentation 
this scoring suggests disease extent rather than disease activity.  
High resolution B-mode ultrasonography is an inexpensive, easily available & sensitive 
tool.  Studies have shown an increase in CIMT in many inflammatory conditions such as 
RA, psoriatic arthritis48, 49 Behcet’s disease and Takayasu’s arteritis50, 51. The arch vessels 
are commonly involved in patients with TA - in 62.85% of the cases in this study.  Hence 
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an ultrasonographic evaluation & CIMT assessment may be helpful in evaluating the 
disease activity in patients with TA.  
Seth et al from their study in 37 patients of Takayasu arteritis concluded that increased 
CCA–IMT is a reliable marker of active disease, especially in the absence of 
angiographically visible carotid disease 55.  Studies assessing CIMT in Takayasu arteritis 
are limited.  
Studies with Carotid ultrasound in TA with / without correlation with activity 
Study No. of patients 
in the study 
CIMT (mm) in Takayasu Arteritis 
Active Inactive Control 
Raninen et al57 16 1.75 ±0.86 0.74 ±0.11  
Seth et al55 37 1.5 ± 0.16 0.9 ± 0.19 0.6 ± 0.13 
Park et al44 10 3.3 ±0.8 1.6 ± 0.4 n/a 
Zielenski et al54 18 1.1 ± 0.1 0.6 ±0.01 
c-CAT study 
(Present study) 
41 1.05 ± 0.33 0.73±.20 0.50 ± 0.06 
 
In our study, we found that the mean CIMT was significantly higher in patients with TA 
than in controls. Among the patients with TA, mean CIMT was higher in active disease 
than in inactive disease. Moreover there was a moderate, statistically significant 
correlation between CIMT and the currently used NIH score & even the validated ITAS 
score. This suggests that CIMT can be used to reliably assess disease activity in patients 
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with TA. We demonstrated a significant association of CIMT ≥ 0.80mm with NIH ≥ 2, 
ITAS ≥ 3 & ESR ≥ 40mm in 1hour. There was no significant association with CRP.  
Even among patients with angiographic arch vessel involvement, the correlations of 
CIMT ≥ 0.80mm were similar. A similar lack of CRP correlation was also seen in one of 
the previous studies. Noris et al37 in their study of cytokines in TA, demonstrated that 
cytokines correlated with the ESR but not with CRP values. This lack of CRP correlation 
however was not adequately explained.   
By NIH criteria, only 36.6% had active disease; whereas by ITAS scoring, 51.2% had 
active disease. This demonstrates the problem of a low sensitivity with NIH scoring 
which is well known. Our institution being a referral centre, many of the TA patients 
were already on treatment with steroids. This may also contribute to the relatively lower 
percentage of patients with active disease in this study.  
In our study, the arch vessels and the infra-diaphragmatic abdominal aorta were most 
commonly involved segments, in 62.85% & 51.21% respectively. This is in keeping with 
the previous studies. Most of the patients were of the angiographic type V. This suggests 
a more extensive disease pattern seen in our patients. This may also be so since most of 
our patients are referrals from elsewhere.  
By this c-CATstudy, abnormal CIMT (≥ 0.80mm) had a sensitivity of 86% & a 
specificity of 61% to detect an active disease, when NIH was used as the gold standard 
for detecting active disease.  But when ITAS was used as the gold standard, a CIMT ≥ 
0.80mm had a sensitivity of 86% & a specificity of 75%. 
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ROC curve analysis demonstrated that the best likelihood ratios were for a CIMT ≥ 
0.85mm & when the gold standard is ITAS. Thus using ITAS as the gold standard & 
CIMT ≥ 0.85mm yield a positive likelihood ratio of 8.10, suggesting a moderate 
likelihood & hence may be better parameters to assess disease activity. It adds 
approximately 40% to the pretest probability of an active disease.  
 
 
LIMITATIONS: 
1. Though a prospective study, it is at best a descriptive single centre, 
nonrandomized study.  
2. Doppler US is operator-dependent although studies have consistently shown that 
when done by trained personnel, CIMT measurement is highly reproducible. 
However much of the limitation can be overcome by using a semi-automated 
border detection program which is available in the newer high end 
ultrasonographic machines.  
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CONCLUSIONS 
 
1. Abnormal CIMT (CIMT ≥ 0.80mm) is an easily available & economical tool that 
can be used to reliably assess disease activity in patients with TA. 
 
2. Using the NIH criteria, CIMT ≥ 0.80mm has a sensitivity of 86% and a specificity 
of 61% to detect active TA. 
 
3. A likelihood ratio of 2.2 for a CIMT ≥ 0.80mm to detect active TA increases to 
8.1 when ITAS is used as the gold standard and the cut-off for an abnormal test is 
a CIMT ≥ 0.85mm. However larger studies need to be done before these changes 
can be incorporated into routine clinical practice. 
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APPENDIX - 1 
 
 
PROFORMA 
 
 
Correlation of CIMT with disease Activity in Takayasu’s Arteritis  
(c-CAT Study) 
 
 
Patient Details:          
 
 
Name of the patient:       Hospital No.:    
 
 
Age/Sex:   
 
 
Address & Telephone No.:  
 
 
 
 
 
 
History: 
 
 
H/o Smoking: Y / N   duration:         H/o Diabetes:  Y / N duration:   
 
  
H/o CVA/ TIA: Y / N   duration:               H/o IHD:  Y / N  duration:  
 
 
H/o  Renal failure: Y /N    duration: 
 
 
 
Laboratory  Data:           (Date of enrolment:              )      
 
 
ESR:        CRP:  
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Examination findings at 1st visit:  
 
 
 
 
 
 
 
 
   
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Site Side Pulses  
 
Blood Pressure Bruit 
 
Carotids Right    
Left    
Subclavian Right    
Left    
Brachial Right    
Left    
Radial Right    
Left    
Femoral Right    
Left    
Popliteal Right    
Left    
D. Pedis Right    
Left    
P. Tibial Right    
Left    
CIMT:  Right Left   
 Proximal 
CCA  
  
Mid 
CCA 
  
Bulb    
Mean   
FIMT    
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Activity at enrolment:  Active / In-Active. 
 
 
     NIH criteria: 
 
   
    
    ITAS score: 
 
 
  
 
 
Angiographic Data at baseline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Right Left 
CCA  
Ostial   
Proximal   
Mid   
Distal   
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APPENDIX - 2 
 
ITAS  – Indian Takayasu Activity Score 
Tick Box only if abnormality is present (new or worse) within past 3 
months.   
Tick box only if abnormality is ascribed to current, active vasculitis. 
Visit Date   : 
Patient  ID 
 
1. SYSTEMIC                     
 None 
Malaise/Wt. Loss>2Kg 
Myalgia/Arthralgia/Arthritis. 
Headache 
Fever 
 
2. MUCOUS MEMBRANES 
 None  
Present 
 
3. EYES 
 None 
Blurred Vision 
Sudden Vision Loss 
Other 
 
4. CHEST 
 None 
Persistent Cough 
Dyspnea/Wheeze 
Hemoptysis/Hemorrhage 
Massive Hemoptysis 
Respiratory Failure 
 
    5. ABDOMEN 
  None  
    Severe Abdominal Pain              
    Bloody Diarrhea               
Gut Perforation/Infarct              
 
6. RENAL 
  None  
Hypertension (Diastole >90)      
     “”          Systolic >140   
Proteinuria (>1+/0.2g/24H)     
Hematuria (>1+/10RBC/ml)    
Creatinine (1.4-2.73 mg/dl)    
Creatinine (2.75-5.5mg/dl)    
Creatinine (>5.5 mg/dl)     
Rise in creatinine >30% or 
> 25% fall in creatinine clearance.    
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7. Nervous System 
  None 
Organic Confusion/Dementia   
Seizures (not hypertensive)     
Stroke      
Syncope      
Cord Lesion     
 
   
8. Genitourinary System 
   None 
Sexual Impotence     
Abortions      
 
 
 
9. CARDIOVASCULAR SYSTEM      
 None                                                                                                   
Bruits (see 9a) 
Pulse Inequality (See 9b) 
 
New Loss of Pulses (See 9c) 
New Loss of pulses with threatened loss of limb. 
 
Claudication (See9d) 
Carotidodynia 
 
Aortic Incompetence 
Pericardial Pain/Rub 
Ischemic Cardiac Pain 
Congestive Cardiac Failure 
 
 
 
  
 
 
 
 
 
 
10. Other Vasc items:     11. Physician Global Opinion (Active / Grumbling or persistent / 
Inactive): 
 
 
 
12.  ESR :             CRP:         
    
 
 
 
 
 
 
 
 
 
Cardiology Opinion/Tests  
No Active Vasculitis     
Pericarditis      
Myocardial Infarct/Angina     
Cardiomyopathy     
 9a. Bruits   R  L 
Carotid      
Vertebral      
Subclavian     
Renal      
Abdominal    
Inguinal      
9b. Pulse and BP Inequality 
Present     
9c. Pulse Loss 
Carotid      
Subclavian     
Brachial      
Radial      
Femoral      
Popliteal      
Posterior Tibial     
Dorsalis Pedis       
9d. Claudication 
Arm     
Leg           
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S.N
o 
Name & Hospital 
Number 
Ag
e 
Se
x 
(Mean of CCA) 
CIMT 
Pulse   Diagnosis & 
Echo 
Right  Left  Right   Left 
1  Kumaravel 607801d  23  M  0.47mm  0.48mm  2+  2+  Normal 
2  Karthick 609969D  20  M  0.40mm  0.47mm  2+  2+  Normal 
3  K Sen 612422D  10  M  0.53mm  0.55mm  2+  2+  Normal 
4  Prita, 613773D  14  F  0.55mm  0.48mm  2+  2+  Normal 
5  Harka k,252034d  41  F  0.52mm  0.47mm  2+  2+  Normal 
6  Karthiyani, 865044c  25  F  0.45mm  0.52mm  2+  2+  Normal 
7  Revathi, 700825c  36  F  0.54mm  0.53mm  2+  2+  Normal 
8  Sandiya, 346244C  23  F  0.48mm  0.45mm  2+  2+  Normal 
9  Saranya, 566412D  20  F  0.55mm  0.50mm  2+  2+  Normal 
10  Sanoj Roy 463731D  30  M  0.53mm  0.53mm  2+  2+  HOCM 
11  Brijesh, 261886D  32  M  0.50mm  0.50mm  2+  2+  Normal 
12  John, 395410B  30  M  0.47mm  0.50mm  2+  2+  Normal 
13  sridevi, 176176d  22  F  0.64mm  0.62mm  2+  2+  CRF 
14  Julius,    30  M  0.53mm  0.54mm  2+  2+  Normal 
15  Reena K, 531977D  19  F  0.51mm  0.53mm  2+  2+  ASD 
16  Sanju , 609694D  18  F  0.43mm  0.42mm  2+  2+  syncope  
17  Ankita das, 291990d  13  F  0.50mm  0.43mm  2+  2+  Normal 
18  Govindammal, 
262348D 
24  F  0.42mm  0.40mm  2+  2+  ?Hemic 
murmur 
19  Sandhya, 610175D  25  F  0.53mm  0.50mm  2+  2+  Normal 
20  Kalpana, 244640D  26  F  0.57mm  0.53mm  2+  2+  VSD, AR 
21  Shobha, 486950D  26  F  0.43mm  0.50mm  2+  2+  MR 
22  Bilashi, 579275D  36  F  0.44mm  0.47mm  2+  2+  post MVR 
23  Phurpa, 626709d  32  F  0.54mm  0.56mm  2+  2+  ILD 
24  shreya, 621486c  22  F  0.47mm  0.47mm  2+  2+  Normal 
25  Priyanka, 628009D  23  F  0.40mm  0.40mm  2+  2+  Normal 
26  Varsha, 629416d  23  F  0.48mm  0.53mm  2+  2+  RSOV to RA 
27  Poongodi,072856d  23  F  0.53mm  0.48mm  2+  2+  ASD 
28  Shobha, 486950d  27  F  0.56mm  0.63mm  2+  2+  Post MVR 
29  Soumitra,  937260A  42  F  0.63mm  0.60mm  2+  2+    ASD 
30  Sivagami,580169d  23  F  0.60mm  0.53mm  2+  2+  Mild MR 
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Figure1 – CIMT measured in the study 
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Figure 2.  Age distribution of the patients 
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Figure 4. Distribution of NIH scores in the study population 
             
Figure 5. Distribution of ITAS scores in the study population 
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                   Figure 7.  Mean CIMT of the patients                                              
                      
        Figure 8. Mean CIMT of the patients by sex distribution 
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Figure 9. Mean CIMT among controls and patients 
               
Figure 10. CIMT among patients with active/inactive disease 
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                       Figure 11. Scatter plot showing the correlation of CIMT with ESR & CRP 
 
 
 
 
Master sheet  - Patient data 
 
 
 
No. Name & Hospital Number Age Sex Activity CIMT (Mean) Pulse CCA angio BP  angio type aneur 
ESR CRP NIH ITAS Right Left Right Left Right Left 
1 Jerusha Lepcha, 394788-D     14 F  55 3.61 2 11 1.00mm   0.91mm  1+      2+    O       O     139/75(100)     I               
2 Dorji, 411886-D                 33 F  27 1.74 0 2 0.91mm   0.78mm  2+      2+    N       N     144/72[100]     V         
3 Sarbani, 373121-D               51 F  60 6.44 2 11 1.00mm   0.96mm  2+      2+    N       N     148/58(88)      V         
4 Baby, 341126-D                  37 F  4 1.74 0 0 0.83mm   0.80mm  3+      3+    N       N     150/80(107)     IV              
5 Jabarani, 333204-D              32 F  34 45.6 2 2 0.65mm   0.59mm  2+      2+    N       N     158/83(105)     IV              
6 Rohina, 331725-D                32 F  65 1.44 1 1 1.26mm   0.66mm  2+      2+    N       N     160/94/91       I               
7 Elcy, 283746-D                  34 F  65 24.9 2 3 0.96mm   0.76mm  2+      2+    N       N     184/87(128)     I               
8 Rani, 013100-C                  33 F  14 11.9 2 4 0.71mm   1.13mm  2+      1+    N       O     170/65(104)     V         
9 Bibekanda, 167351-B             51 M  34 4.59 0 2 0.57mm   0.59mm  2+      2+    N       N     110/80 V         
10 Janaki.C., 005493-D             31 F  5 39 2 2 0.53mm   0.67mm  2+      2+    N       N     144/76[101]     III             
11 Yuvaraj, 456622-D               18 M  15 29.7 2 5 0.44mm   2.07mm  2+      1+    N       N     106/81 (94)     IIa     +       
12 Gayathri, 417815-D              25 F  25 30 1 0 0.53mm   0.55mm  2+      2+    N       A     190/110 (140)  V +       
13 Suparna, 534311-D               13 F  20 36 1 6 0.54mm   0.84mm  2+      1+    N       A     135/72 (98)     V         
14 Tamilselvi, 346764-D            24 F  30 33.3 1 2 0.45mm   0.42mm  2+      2+    N       N     130/80          V         
15 Vidyapraveena, 366826-D       29 F  15 5.82 0 2 0.62mm   0.73mm  2+      2+    N       N     142/95(117)     I               
16 Padmini, 438036-D               27 F  125 65.9 3 12 1.85mm   2.00mm  2+      2+    N       A     108/61 (86)     I               
17 Prateek, 534438-D               10 M  30 7.76 1 2 0.69mm   0.62mm  2+      2+    N       N     96/70           IV              
18 Rochana, 517508-D               15 F  24 7.69 1 2 0.49mm   0.55mm  2+      2+    N       N     180/89          V         
19 Manpi, 196066-d                 12 F  35 3.3 0 2 0.86mm   0.80mm  2+      2+    N       N     143/72/101 IV              
20 Nandita, 041168-D               24 F  12 0.154 0 1 0.61mm   0.49mm  2+      2+    N       N     134/83(109)     I               
21 Pinki Das, 309437-D             26 F  28 1.27 0 6 0.59mm   1.36mm  2+      1+    N       A     140/50          V         
22 Manjunath, 586990-D             32 M  15 1.26 0 2 0.41mm   0.55mm  3+      1+    A       O     170/80 I               
23 Tushara, 380493-B               27 F  21 0.821 0 0 0.85mm   1.26cm  2+      0 A       A     114/50(80)      I               
24 Ashok, 621740-C                 25 M  120 39.3 2 4 0.60mm   1.06mm  2+      1+    N       O     170/100 V +       
25 Santhosh,930583-C               16 M  33 3.08 0 2 0.53mm   0.66mm  2+      2+    N       N     140/77(106)     IV              
 
 
 
 
Master sheet  - Patient data 
 
 
 
No. Name & Hospital Number Age Sex 
Activity
CIMT (Mean) Pulse CCA angio BP  
angio 
type aneur ESR CRP NIH ITAS Right Left Right Left Right Left
26 Anju, 977967-C                  25 F  85 38.1 3 6 1.32mm   1.12mm  1+      2+    A       N     142/71(102)     I               
27 Sabika, 539802-C                22 F  21 2.66 1 2 0.59mm   0.57mm  2+      2+    N       N     150/90 IV              
28 Eldrick, 475512b,               63 M  39 9.2 1 9 1.17mm   0.84mm  2+      1+    N       O     220/100 V         
29 Chinni, 384603D,                16 M  28 25.1 2 4 1.51mm   1.16mm  2+      2+    A       A     113/66(85)      IIa     +       
30 Laltu, 498217D 25 M 7 0.66 0 11 0.62mm 0.68mm 3+ 3+ N N 146/72(101) III 
31 Malna, 435520C 30 F 52 14.3 2 4 1.07mm 0.92mm 1+ 2+ N N 153/78(98) I 
32 Sumita, 431470D,                30 F  33 16.5 2 12 0.82mm    0.97mm  2+      0 N       A     175/101 (127)  V         
33 Krishnaveni, 058242C           48 F  10 2.76 2 4 1.60mm   1.20mm  2+      2+    A       N     130/70 V             
34 Biplobi Barua, 323132D,        35 F  50 1.2 1 4 0.93mm   1.40mm  2+      1+    N       N     120/80          I               
35 Chitra Maya, 269071D           16 F  50 12.8 2 4 0.96mm   1.13mm  2+      2+    A       N     147/85 (111)    V             
36 Phub Wagmo, 558209C          22 F  12 19 1 3 0.94mm   0.93mm  2+      2+    N       N     121/57(75)      V       +       
37 Jasmin Begum, 174566D,       35 F  37 12.1 1 2 0.68mm   0.73mm  2+      2+    N       N     104/70          V         
38 Sashukumari, 716696C           28 F  22 10.3 1 2 0.57mm   0.55mm  2+      2+    N       N     100/70 V         
39 G. Jaya, 517647D               45 F  30 0.16 0 0 0.78mm   0.61mm  2+      2+    N       N     170/90 IV      +       
40 Neera Jakshi, 423840D          23 F  57 1.03 1 5 0.71mm   0.52mm  2+      2+    N/A     N/A   140/90 N/A             
41 Patel Kishore, 308484D          42 M  10 3.15 1 4 0.96mm   0.80mm  2+      2+    N/A     N/A   130/90 N/A             
 
 
 
